NEW DAWN FOR MD : EXPLORING CUTTING-EDGE MUSCULAR DYSTROPHY TREATMENTS

For years, muscular dystrophy (MD) has presented a daunting dilemma to patients and families worldwide. However, recent advances in research offer a beacon of hope for the future. Scientists are tirelessly working on groundbreaking treatments that aim to not only manage symptoms but also to halt the progression of this debilitating disease. One pa

both of those pairwise and community meta-analyses indicated that only methylphenidate was more effective than placebo/Manage. There was an absence of outstanding efficacy of other antidepressants as opposed with placebo. It differs from the outcomes of other meta-analyses described previously [fifty six,fifty seven], suggesting that enormous-scale